CURE Pharmaceutical Holding, which is developing oral dissolving film formulations of existing drugs, announced terms for its IPO on Friday. Its stock is currently traded on the OTCQX under the symbol CURR.
The Oxnard, CA-based company plans to raise $12 million by offering 2 million shares at a price range of $5 to $7. At the midpoint of the proposed range, CURE Pharmaceutical Holding would command a fully diluted market value of $78 million.
CURE Pharmaceutical Holding was founded in 2011 and plans to list on the Nasdaq under the symbol CURR. Network 1 Financial Securities is the sole bookrunner on the deal.
